"New Hope Podiatry Group has been serving Southern California for over 20 years. With a team Foot and Ankle Specialists, Surgeons and Wound Care Experts. We have over 10 Years Experience with Workman’s Compensation and Personal Injury cases. We treat the most common foot issues to performing complex reconstructive surgeries."

During the past decade, New Hope Podiatry Group conducted 9 clinical trials. In the 10-year time frame, 9 clinical trials started and 1 clinical trials were completed, i.e. on average, 11.1% percent of trials that started reached the finish line to date. In the past 5 years, 5 clinical trials started and 1 clinical trials were completed. i.e. 20% of trials that started reached the finish line.

Out of the total clinical trials conducted in "New Hope Podiatry Group" #1 sponsor was "SerenaGroup, Inc." with 2 trials, followed by "Axogen Corporation" with 1 trials sponsored, "Inotec AMD Limited" with 1 trials sponsored, "MolecuLight Inc." with 1 trials sponsored and "Omeza, LLC" with 1 trials sponsored. Other sponsors include -2 different institutions and companies that sponsored additional 8 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "New Hope Podiatry Group" #1 collaborator was "SerenaGroup, Inc." with 2 trials as a collaborator, "Alira Health" with 1 trials as a collaborator, "TR Therapeutics" with 1 trials as a collaborator and "Tides Medical" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 4 trials.

According to Clinical.Site data, the most researched conditions in "New Hope Podiatry Group" are "Diabetic Foot" (2 trials), "Venous Leg Ulcer" (2 trials), "Chronic Diabetic Foot Ulcers" (1 trials), "Chronic Nerve Pain" (1 trials) and "Chronic Ulcer" (1 trials). Many other conditions were trialed in "New Hope Podiatry Group" in a lesser frequency.

Most popular intervention types in "New Hope Podiatry Group" are "Device" (5 trials), "Biological" (2 trials), "Drug" (2 trials), "Other" (2 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "0.1% TR 987" (1 trials), "ActiGraft" (1 trials), "AxoGuard® Nerve Cap" (1 trials), "Control" (1 trials) and "Dual Layer Amniotic Membrane (DLAM). Artacent®" (1 trials). Other intervention names were less common.

The vast majority of trials in "New Hope Podiatry Group" are 9 trials for "All" genders.

Currently, there are NaN active trials in "New Hope Podiatry Group". undefined are not yet recruiting, 3 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in New Hope Podiatry Group, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in New Hope Podiatry Group, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 4 trials that are defined as “Not Applicable".